International Clinical Trial: A randomized, double-blind, placebo-controlled human clinical trial to evaluate the efficacy and safety of kelp extract powder for improving immune function

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (KCT0011648) titled 'A randomized, double-blind, placebo-controlled human clinical trial to evaluate the efficacy and safety of kelp extract powder for improving immune function' on Feb. 25.

Study Type: Interventional Study

Study Design: Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Semyung University Oriental Medicine Hospital

Condition:

Symptoms, signs and abnormal clinical and laboratory findings, NEC

Intervention: Dietary Supplement : The main active ingredient of the test food is kelp extract powder (FucoR...